tiprotimod has been researched along with Candida Infection in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dickneite, G; Schorlemmer, HU; Sedlacek, HH | 1 |
| Dickneite, G; Dürckheimer, W; Hänel, H; Schorlemmer, HU; Sedlacek, HH | 1 |
2 other study(ies) available for tiprotimod and Candida Infection
| Article | Year |
|---|---|
Influence of the immunostimulating substance tiprotimod on Candida albicans infection in relation to activation of macrophages.
Topics: Adjuvants, Immunologic; Animals; Candidiasis; Dextran Sulfate; Dextrans; Drug Therapy, Combination; Escherichia coli; Female; Free Radicals; Ketoconazole; Macrophage Activation; Macrophages; Mice; Mice, Inbred BALB C; Mice, Nude; Superoxides; Thiazoles | 1989 |
Immunomodulation by the new synthetic thiazole derivative tiprotimod. 3rd communication: influence on host resistance to microorganisms, tumors and on experimental immune disorders.
Topics: Adjuvants, Immunologic; Anemia, Hemolytic, Autoimmune; Animals; Candida albicans; Candidiasis; Female; Graft vs Host Reaction; Male; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Mice, Inbred DBA; Mice, Inbred Strains; Rats; Sepsis; Skin Transplantation; Thiazoles | 1989 |